Search research articles
Contact Us
Filters
Showing results (21-30 of 73) with videos related to
Page
of 8
Sort By:
Anticancer Research
|
June 27, 2025
The Conditions of Non-rescuability of Methioninase-treated Cancer Cells by Methionine Replenishment: The Point of No Return
Byung Mo Kang, Qinghong Han, Shukuan Li, et al.
Cancer Diagnosis & Prognosis
|
September 6, 2024
Imaging Transgenic Nude Mice Expressing Spectrally-distinct Fluorescent Reporters Emitting From Blue to Far Red Light With One Instrument With Single-nanometer-tuning of Laser-excitation Fluorescence
Kohei Mizuta, Jose Reynoso, Sean Gallagher, et al.
Cancer Diagnosis & Prognosis
|
May 4, 2026
The Combination of Methionine Adenosyltransferase 2A (MAT2A) Inhibitor AG-270 and Recombinant Methioninase Is Not Cancer-selective in a Co-culture Model of Colon Cancer Cells and Normal Fibroblasts
Jinsoo Kim, Qinghong Han, Shukuan Li, et al.
Anticancer Research
|
November 29, 2025
The Combination of Recombinant Methioninase and Low-dose Chloroquine Selectively Eradicates Colon-Cancer Cells Without Apparent Toxicity on Co-cultured Normal Fibroblasts
Jinsoo Kim, Qinghong Han, Shukuan Li, et al.
Anticancer Research
|
December 30, 2025
Effect of Recombinant Methioninase Dose and Timing on the Selective and Precise Elimination of Cancer Cells from Co-Cultured Normal Cells and on Methionine-dependent Rescue of Cancer Cells
Jinsoo Kim, Qinghong Han, Shukuan Li, et al.
Anticancer Research
|
October 28, 2025
Simultaneous Targeting of Multiple Hallmarks of Cancer With Recombinant Methioninase, Rapamycin and Chloroquine Is Specific and Synergistic to MiaPaCa-2 Pancreatic-Cancer Cells in Contrast to Hs-27 Normal Fibroblasts
Jinsoo Kim, Qinghong Han, Shukuan Li, et al.
Cancer Diagnosis & Prognosis
|
November 6, 2023
Recombinant Methioninase Lowers the Effective Dose of Regorafenib Against Colon-Cancer Cells: A Strategy for Widespread Clinical Use of a Toxic Drug
Brad Barsam Choobin, Yutaro Kubota, Qinghong Han, et al.
Anticancer Research
|
January 30, 2026
Lack of Cancer Specificity of Methionine Adenosyltransferase 2A (MAT2A) Inhibitor AG-270 in Combination With Recombinant Methioninase <i>In Vitro</i>
Jinsoo Kim, Qinghong Han, Shukuan Li, et al.
In Vivo (Athens, Greece)
|
February 27, 2026
Methionine Restriction Alone Induces T-cell-mediated Immunotherapy of Osteosarcoma in a Syngeneic Mouse Model
Kohei Mizuta, Yutaro Kubota, Yusuke Aoki, et al.
Anticancer Research
|
September 26, 2025
Recombinant Methioninase Selectively Eliminates Cancer Cells Co-cultured With Normal Fibroblasts Indicating the High-Precision Efficacy of Targeting Methionine Addiction of Cancer
Byung Mo Kang, Qinghong Han, Shukuan Li, et al.
Page
of 8
Search research articles
Search
Showing results (21-30 of 73) with videos related to
Sort By:
Page
of 8
Anticancer Research
|
June 27, 2025
The Conditions of Non-rescuability of Methioninase-treated Cancer Cells by Methionine Replenishment: The Point of No Return
Byung Mo Kang, Qinghong Han, Shukuan Li, et al.
Cancer Diagnosis & Prognosis
|
September 6, 2024
Imaging Transgenic Nude Mice Expressing Spectrally-distinct Fluorescent Reporters Emitting From Blue to Far Red Light With One Instrument With Single-nanometer-tuning of Laser-excitation Fluorescence
Kohei Mizuta, Jose Reynoso, Sean Gallagher, et al.
Cancer Diagnosis & Prognosis
|
May 4, 2026
The Combination of Methionine Adenosyltransferase 2A (MAT2A) Inhibitor AG-270 and Recombinant Methioninase Is Not Cancer-selective in a Co-culture Model of Colon Cancer Cells and Normal Fibroblasts
Jinsoo Kim, Qinghong Han, Shukuan Li, et al.
Anticancer Research
|
November 29, 2025
The Combination of Recombinant Methioninase and Low-dose Chloroquine Selectively Eradicates Colon-Cancer Cells Without Apparent Toxicity on Co-cultured Normal Fibroblasts
Jinsoo Kim, Qinghong Han, Shukuan Li, et al.
Anticancer Research
|
December 30, 2025
Effect of Recombinant Methioninase Dose and Timing on the Selective and Precise Elimination of Cancer Cells from Co-Cultured Normal Cells and on Methionine-dependent Rescue of Cancer Cells
Jinsoo Kim, Qinghong Han, Shukuan Li, et al.
Anticancer Research
|
October 28, 2025
Simultaneous Targeting of Multiple Hallmarks of Cancer With Recombinant Methioninase, Rapamycin and Chloroquine Is Specific and Synergistic to MiaPaCa-2 Pancreatic-Cancer Cells in Contrast to Hs-27 Normal Fibroblasts
Jinsoo Kim, Qinghong Han, Shukuan Li, et al.
Cancer Diagnosis & Prognosis
|
November 6, 2023
Recombinant Methioninase Lowers the Effective Dose of Regorafenib Against Colon-Cancer Cells: A Strategy for Widespread Clinical Use of a Toxic Drug
Brad Barsam Choobin, Yutaro Kubota, Qinghong Han, et al.
Anticancer Research
|
January 30, 2026
Lack of Cancer Specificity of Methionine Adenosyltransferase 2A (MAT2A) Inhibitor AG-270 in Combination With Recombinant Methioninase <i>In Vitro</i>
Jinsoo Kim, Qinghong Han, Shukuan Li, et al.
In Vivo (Athens, Greece)
|
February 27, 2026
Methionine Restriction Alone Induces T-cell-mediated Immunotherapy of Osteosarcoma in a Syngeneic Mouse Model
Kohei Mizuta, Yutaro Kubota, Yusuke Aoki, et al.
Anticancer Research
|
September 26, 2025
Recombinant Methioninase Selectively Eliminates Cancer Cells Co-cultured With Normal Fibroblasts Indicating the High-Precision Efficacy of Targeting Methionine Addiction of Cancer
Byung Mo Kang, Qinghong Han, Shukuan Li, et al.
Page
of 8